Gingicaine Gel
Product Images NDC 10129-035

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel (NDC 10129-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

This text provides a cautionary warning for Gingicaine Gel products, advising that they should be kept away from children and that immediate medical attention should be sought if a child swallows or ingests Gingicaine Gel.*

FDA Label Image

Contraindications

The product has contraindications for patients who have a history of hypersensitivity to ester-type local anesthetics. It is not recommended for teething, infants, and children under 2 years old.*

FDA Label Image

Gingicaine Banana Jar Label

This is a drug information for a product containing 20% benzocaine, an oral anesthetic, for the reduction of pain or discomfort that is caused by minor dental procedures, minor gum injury, canker sores, sore throat, minor mouth or gum irritations caused by dentures or orthodontic appliances. It contains several allergy alerts, warnings, dosage & administration directions, indications, and precautions. It is manufactured by Gingi-Pak and should only be used by adults and children over 2 years old.*

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

This is a description of an oral anesthetic that contains 20% w/v of the active ingredient benzocaine.*

FDA Label Image

Allergy Alert002 (Gingicaine Allergy Alert 002)

This text is a warning for people who have allergy to "caine" local anesthetics. It advises them not to use such product.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

This text provides a warning to avoid exposing something to temperatures exceeding 40 °C (104 °F).*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

This text provides instructions for applying local anesthesia with minimal dilution using cotton rolls or saliva ejectors. It emphasizes the use of sterile cotton or gauze to avoid cross-contamination and advises against exceeding the recommended dosage. This product is intended for adults and children over 2 years old, and children under 2 years old are advised to consult with a dentist or doctor.*

FDA Label Image

Indication (Gingicaine Indications 001)

This text describes the intended use of a product or substance for the anesthesia of mucous membranes in the oropharynx. It effectively reduces pain in procedures such as ulcers, needle puncture, scaling, and the application of matrix bands. Additionally, it can be used to help patients who experience an excessive gag reflex during the taking of impressions or intraoral radiographs.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

This text appears to be a set of precautions related to the use of local anesthetics by dentists. It warns against applying the anesthetics to infected or severely traumatized areas, as well as areas that may render protective reflexes. The text also suggests caution when using anesthetics with patients who have drug sensitivities or allergies to ester-type anesthetics such as procaine, benzocaine, and tetracaine. Finally, it advises dentists to avoid contact with all anesthetics to prevent the possibility of sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

This is a medication or product that is used to reduce pain or discomfort caused by various dental issues like minor dental procedures, minor gum injury, canker sores, sore throat, minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Gingicaine Gel Banana-hakusui (Gingicaine Gel Label Jpn Eng)

This is a description for a dental topical anesthetic called Gingicaine-Gel 20% that contains 20g of Ethyl Aminobenzoate. The gel has a banana flavor and comes in a 30g package. The Marketing Authorization Holder is Hakusui Trading Co., Ltd. located in Osaka, Japan. This product must be used only with a prescription of a doctor. The precautions for use should be read from the package insert carefully before use. The information regarding the Manufacturing no. (LOT) and Medical Drug Approval No. are not available. The product expiry date is provided.*

FDA Label Image

Inactive Ingredient (Inactive Ingredient Page 001)

Polyethylene Glycol 3350 and Polyethylene Glycol 400 are chemical compounds often used as laxatives to treat constipation. They work by softening the stool and increasing the frequency of bowel movements. Potassium Sodium Saccharate is a sweetener and flavoring agent commonly used in food and beverage products.*

FDA Label Image

Purpose (Purpose Page 001)

Gingicaine Gel is a topical anesthetic used by Dentists just prior to an injection. Gingicaine is usually spread on a patients gum.*

FDA Label Image

Warnings

This text is a warning about using a certain product, indicating that it can cause a rare condition called methemoglobinemia that reduces the amount of oxygen in the blood, and that it should only be used externally. It advises discontinuing use and seeking medical attention if symptoms such as pale, gray, or blue colored skin, headaches, rapid heartbeat, shortness of breath, dizziness, lightheadedness, fatigue, or lack of energy occur. It also states that the product should not be used in children under 2 years of age.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.